Xue Chen Li

Director/Board Member en YICHANG HEC CHANGJIANG PHARMACEUTICAL CO., LTD. .

Fortuna: 6 628 $ al 30/04/2024

47 años

Consumer Services

Health Technology

Perfil

Xue Chen Li is an Independent Non-Executive Director at YiChang HEC ChangJiang Pharmaceutical Co., Ltd.
and a Director at HEC Pharm Co., Ltd.
He holds a doctorate degree from Harvard University, a graduate degree from the University of Alberta, and an undergraduate degree from Nankai University.

Participaciones conocidas en empresas públicas

Empresa	Fecha	Número de acciones	Valoración	Fecha de valoración
YICHANG HEC CHANGJIANG PHARMACEUTICAL CO. LTD. CLASS H 0.00%	30/06/2023	4 000 ( 0.00% )	6 628 $	30/04/2024

Cargos activos de Xue Chen Li

Empresas	Cargo	Inicio
YICHANG HEC CHANGJIANG PHARMACEUTICAL CO., LTD.	Director/Board Member	25/09/2020
HEC Pharm Co., Ltd. HEC Pharm Co., Ltd. Pharmaceuticals: MajorHealth Technology Yichang Dongyang Changjiang Pharmaceuical Co. Ltd. manufactures pharmaceutical products. The Company mainly develops, produces, and distributes active pharmaceutical ingredients and insulins. The firm focuses on anti-virus, endocrine and metabolic diseases and cardiovascular diseases. The company was founded on August 08, 2001and is headquartered in Dongguan, China.	Director/Board Member	-

Todos los cargos activos de Xue Chen Li

Formación de Xue Chen Li.

Harvard University	Doctorate Degree
University of Alberta	Graduate Degree
Nankai University	Undergraduate Degree

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Xue Chen Li.

Relaciones

100 +

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas cotizadas	1
YICHANG HEC CHANGJIANG PHARMACEUTICAL CO., LTD.	Health Technology

Empresas privadas	1
HEC Pharm Co., Ltd. HEC Pharm Co., Ltd. Pharmaceuticals: MajorHealth Technology Yichang Dongyang Changjiang Pharmaceuical Co. Ltd. manufactures pharmaceutical products. The Company mainly develops, produces, and distributes active pharmaceutical ingredients and insulins. The firm focuses on anti-virus, endocrine and metabolic diseases and cardiovascular diseases. The company was founded on August 08, 2001and is headquartered in Dongguan, China.	Health Technology